Quality of Life Among Men Treated With External Beam Radiation Therapy for Prostate Cancer

2.50
Hdl Handle:
http://hdl.handle.net/10755/161243
Type:
Presentation
Title:
Quality of Life Among Men Treated With External Beam Radiation Therapy for Prostate Cancer
Abstract:
Quality of Life Among Men Treated With External Beam Radiation Therapy for Prostate Cancer
Conference Sponsor:Midwest Nursing Research Society
Conference Year:2005
Author:Ward-Smith, Peggy, PhD, RN
P.I. Institution Name:University of Missouri - Kansas City
Title:Assistant Professor
Contact Address:School of Nursing, 2220 Holmes, Kansas, MO, 64108, USA
Contact Telephone:816/235-5960
In 2004, more than 229,900 men will be diagnosed with prostate cancer,
making it the second leading cause of cancer death in the United States.
There are many treatment choices for this disease, each demonstrating
similar survival curves. The American Urological Association has
recommended that quality of life (QoL) be included as a treatment outcome
measure. The purpose of this study was to allow men, treated with external
beam radiation therapy, to self-evaluate their QoL. The FACT-P, a 39-item
Likert scale instrument that measures QoL, was administered to 59 men
before and 3, 6 and 12 months after treatment. Data analysis by ANOVA,
t-tests and Least Significant Difference Post-Hoc testing reveal a
statistically significant difference in physical well-being between 6 and
12 months, in social well-being at all data collection intervals and in
the specific prostate concerns subscale at 3 months after treatment. The
results of this study indicate that QoL is affected by treatment, and
these effects endure throughout the first year after treatment. This
information may impact treatment choice and should be included in patient
education.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Midwest Nursing Research Society

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleQuality of Life Among Men Treated With External Beam Radiation Therapy for Prostate Canceren_GB
dc.identifier.urihttp://hdl.handle.net/10755/161243-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Quality of Life Among Men Treated With External Beam Radiation Therapy for Prostate Cancer</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Midwest Nursing Research Society</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2005</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Ward-Smith, Peggy, PhD, RN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">University of Missouri - Kansas City</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">School of Nursing, 2220 Holmes, Kansas, MO, 64108, USA</td></tr><tr class="item-phone"><td class="label">Contact Telephone:</td><td class="value">816/235-5960</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">wardsmithp@umkc.edu</td></tr><tr><td colspan="2" class="item-abstract">In 2004, more than 229,900 men will be diagnosed with prostate cancer, <br/> making it the second leading cause of cancer death in the United States. <br/> There are many treatment choices for this disease, each demonstrating <br/> similar survival curves. The American Urological Association has <br/> recommended that quality of life (QoL) be included as a treatment outcome <br/> measure. The purpose of this study was to allow men, treated with external <br/> beam radiation therapy, to self-evaluate their QoL. The FACT-P, a 39-item <br/> Likert scale instrument that measures QoL, was administered to 59 men <br/> before and 3, 6 and 12 months after treatment. Data analysis by ANOVA, <br/> t-tests and Least Significant Difference Post-Hoc testing reveal a <br/> statistically significant difference in physical well-being between 6 and <br/> 12 months, in social well-being at all data collection intervals and in <br/> the specific prostate concerns subscale at 3 months after treatment. The <br/> results of this study indicate that QoL is affected by treatment, and <br/> these effects endure throughout the first year after treatment. This <br/> information may impact treatment choice and should be included in patient <br/> education.</td></tr></table>en_GB
dc.date.available2011-10-26T23:18:13Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T23:18:13Z-
dc.description.sponsorshipMidwest Nursing Research Societyen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.